Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 7, 2013; 19(37): 6214-6220
Published online Oct 7, 2013. doi: 10.3748/wjg.v19.i37.6214
Figure 1
Figure 1 Longitudinal representation of hepatitis B reactivation after chemotherapy in patients with hematological malignancies. HBsAg: Hepatitis B surface antigen; anti-HBc: Antibody to hepatitis B core antigen; HBV: Hepatitis B virus.
Figure 2
Figure 2 The complete genome of the hepatitis B virus was isolated and sequenced (case 1) prior to the start of chemotherapy (case 1-A) and after the emergence of hepatitis B virus reactivation (case 1-B). The phylogenetic analysis demonstrated that the patient (case 1) developed an hepatitis B virus (HBV) reactivation of an occult HBV infection.